Anti-müllerian hormone regulation by the bone morphogenetic proteins in the sheep ovary: Deciphering a direct regulatory pathway

Endocrinology

Volumn 156, Issue 1, 2015, Pages 301-313

  Estienne, Anthony ^a,b   Pierre, Alice ^c   Di Clemente, Nathalie ^d   Picard, Jean Yves ^e   Jarrier, Peggy ^a,b   Mansanet, Camille ^a,b   Monniaux, Danielle ^a,b   Fabre, Stéphane ^f  

^a UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSERM   (France)

^e CNRS   (France)

^f UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; MESSENGER RNA; MUELLERIAN INHIBITING FACTOR; SF1 PROTEIN; SMAD1 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BONE MORPHOGENETIC PROTEIN RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; EWE; FEMALE; GENE EXPRESSION REGULATION; GRANULOSA CELL; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SYNTHESIS; LOSS OF FUNCTION MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY FOLLICLE CELL; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; CELL CULTURE; GENETIC TRANSFECTION; GENETICS; GENOTYPE; HUMAN; METABOLISM; MUTATION; PHYSIOLOGY; SHEEP;

ANIMALS; ANTI-MULLERIAN HORMONE; BINDING SITES; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; GRANULOSA CELLS; HUMANS; MUTATION; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SHEEP; TRANSFECTION;

EID: 84919775198     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1551     Document Type: Article

References (78)

1. Cate RL, Mattaliano RJ, Hession C, et al. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell. 1986;45:685-698
2. Allard S, Adin P, Gouédard L, et al. Molecular mechanisms of hormone-mediated Müllerian duct regression: Involvement of ß-catenin. Development. 2000;127:3349-3360
3. Picard JY, Benarous R, Guerrier D, Josso N, Kahn A. Cloning and expression ofcDNAfor anti-müllerian hormone. Proc Natl Acad Sci USA. 1986;83:5464-5468
4. di Clemente N, Wilson C, Faure E, et al. Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Mol Endocrinol. 1994;8:1006-1020
5. Lee MM, Donahoe PK. Mullerian inhibiting substance: A gonadal hormone with multiple functions. Endocr Rev. 1993;14:152-164
6. Teixeira J, Maheswaran S, Donahoe PK. Müllerian inhibiting substance: An instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev. 2001;22:657-674
7. Josso N, Clemente N. Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF-ß family. Trends Endocrinol Metab. 2003;14:91-97
8. Durlinger AL, Kramer P, Karels B, et al. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology. 1999;140:5789-5796
9. Durlinger AL, Gruijters MJ, Kramer P, et al. Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology. 2002;143:1076-1084
10. Gigli I, Cushman RA, Wahl CM, Fortune JE. Evidence for a role for anti-Mullerian hormone in the suppression of follicle activation in mouse ovaries and bovine ovarian cortex grafted beneath the chick chorioallantoic membrane. Mol Reprod Dev. 2005;71:480-488
11. Di Clemente N, Goxe B, Remy JJ, et al. Inhibitory effect of AMH upon the expression of aromatase and LH receptors by cultured granulosa cells of rat and porcine immature ovaries. Endocrine. 1994;2:553-558
12. Durlinger AL, Gruijters MJ, Kramer P, et al. Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology. 2001;142:4891-4899
13. Campbell BK, Clinton M, Webb R. The role of anti-Müllerian hormone( AMH)during follicle development in a monovulatory species (sheep). Endocrinology. 2012;153:4533-4543
14. Visser JA, Themmen AP. Role of anti-Müllerian hormone and bone morphogenetic proteins in the regulation of FSH sensitivity. Mol Cell Endocrinol. 2014;382:460-465
15. Baarends WM, Uilenbroek JT, Kramer P, et al. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology. 1995;136:4951-4962
16. Hirobe S, He WW, Gustafson ML, MacLaughlin DT, Donahoe PK. Müllerian inhibiting substance gene expression in the cycling rat ovary correlates with recruited or graafian follicle selection. Biol Reprod. 1994;50:1238-1243
17. Rico C, Fabre S, Médigue C, et al. Anti-mullerian hormone is an endocrine marker of ovarian gonadotropin-responsive follicles and can help to predict superovulatory responses in the cow. Biol Reprod. 2009;80:50-59
18. van Rooij IA, Broekmans FJ, te Velde ER, et al. Serum anti-Müllerian hormone levels: A novel measure of ovarian reserve. Hum Reprod. 2002;17:3065-3071
19. Kevenaar ME, Meerasahib MF, Kramer P, et al. Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology. 2006;147:3228-3234
20. GrynbergM,Pierre A, Rey R, et al. Differential regulation of ovarian anti-müllerian hormone (AMH) by estradiol through ß-And ß-estrogen receptors. J Clin Endocrinol Metab. 2012;97:E1649-E1657
21. Taieb J, Grynberg M, Pierre A, et al. FSH and its second messenger cAMP stimulate the transcription of human anti-Müllerian hormone in cultured granulosa cells. Mol Endocrinol. 2011;25:645-655
22. Arango NA, Lovell-Badge R, Behringer RR. Targeted mutagenesis of the endogenous mouse Mis gene promoter: In vivo definition of genetic pathways of vertebrate sexual development. Cell. 1999;99: 409-419
23. Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flanagan JN, Hammer GD, Ingraham HA. Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell. 1998;93:445-454
24. Tremblay JJ, Viger RS. Nuclear receptor Dax-1 represses the transcriptional cooperation between GATA-4 and SF-1 in Sertoli cells. Biol Reprod. 2001;64:1191-1199
25. Beau C, Rauch M, Joulin V, Jégou B, Guerrier D. GATA-1 is a potential repressor of anti-Müllerian hormone expression during the establishment of puberty in the mouse. Mol Reprod Dev. 2000; 56:124-138
26. Shi J, Yoshino O, Osuga Y, et al. Bone morphogenetic protein-6 stimulates gene expression of follicle-stimulating hormone receptor, inhibin/activin ß subunits, and anti-Müllerian hormone in human granulosa cells. Fertil Steril. 2009;92:1794-1798
27. Rico C, Médigue C, Fabre S, Jarrier P, Bontoux M, Clément F, Monniaux D. Regulation of anti-Mullerian hormone production in the cow: A multiscale study at endocrine, ovarian, follicular, and granulosa cell levels. Biol Reprod. 2011;84:560-571
28. Monniaux D, Drouilhet L, Rico C, et al. Regulation of anti-Müllerian hormone production in domestic animals. Reprod Fertil Dev. 2012;25:1-16
29. Ocón-Grove OM, Poole DH, Johnson AL. Bone morphogenetic protein 6 promotes FSH receptor and anti-Müllerian hormone mRNA expression in granulosa cells from hen prehierarchal follicles. Reproduction. 2012;143:825-833
30. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, MatzukMM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature. 1996;383:531-535
31. Yan C, Wang P, DeMayo J, et al. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol. 2001;15:854-866
32. Pangas SA. Bone morphogenetic protein signaling transcription factor (SMAD) function in granulosa cells. Mol Cell Endocrinol. 2012; 356:40-47
33. Galloway SM, McNatty KP, Cambridge LM, et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet. 2000;25:279-283
34. Mulsant P, Lecerf F, Fabre S, et al. Mutation in bone morphogenetic protein receptor-IB is associated with increased ovulation rate in Booroola Mérino ewes. Proc Natl Acad Sci USA. 2001;98:5104-5109
35. Wilson T, Wu XY, Juengel JL, et al. Highly prolific Booroola sheep have a mutation in the intracellular kinase domain of bone morphogenetic protein IB receptor (ALK-6) that is expressed in both oocytes and granulosa cells. Biol Reprod. 2001;64:1225-1235
36. Hanrahan JP, Gregan SM, Mulsant P, et al. Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biol Reprod. 2004;70:900-909
37. Nicol L, Bishop SC, Pong-Wong R, et al. Homozygosity for a single base-pair mutation in the oocyte-specific GDF9 gene results in sterility in Thoka sheep. Reproduction. 2009;138:921-933
38. Elvin JA, Yan C, Matzuk MM. Oocyte-expressed TGF-ß superfamily members in female fertility. Mol Cell Endocrinol. 2000;159:1-5
39. Knight PG, Glister C. TGF-ß superfamily members and ovarian follicle development. Reproduction. 2006;132:191-206
40. Otsuka F, Moore RK, Shimasaki S. Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary. J Biol Chem. 2001;276:32889-32895
41. Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson GF, Shimasaki S. Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem. 2000;275:39523-39528
42. Pierre A, Pisselet C, Dupont J, et al. Molecular basis of bone morphogenetic protein-4 inhibitory action on progesterone secretion by ovine granulosa cells. J Mol Endocrinol. 2004;33:805-817
43. Mazerbourg S, Sangkuhl K, Luo CW, Sudo S, Klein C, Hsueh AJ. Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analyses. J Biol Chem. 2005;280:32122-32132
44. Mazerbourg S, Hsueh AJ. Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands. Hum Reprod Update. 2006;12:373-383
45. Peng J, Li Q, Wigglesworth K, et al. Growth differentiation factor 9:bone morphogenetic protein 15 heterodimers are potent regulators of ovarian functions. Proc Natl Acad SciUSA. 2013;110:E776-E785
46. Moore RK, Otsuka F, Shimasaki S. Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells. J Biol Chem. 2003;278:304-310
47. Mazerbourg S, Klein C, Roh J, et al. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. Mol Endocrinol. 2004;18:653-665
48. Mottershead DG, Ritter LJ, Gilchrist RB. Signalling pathways mediating specific synergistic interactions between GDF9 and BMP15. Mol Hum Reprod. 18:121-128
49. Souza CJ, Campbell BK, McNeilly AS, Baird DT. Effect of bone morphogenetic protein 2 (BMP2) on oestradiol and inhibin A production by sheep granulosa cells, and localization of BMP receptors in the ovary by immunohistochemistry. Reproduction. 2002;123: 363-369
50. Fabre S, Pierre A, Pisselet C, et al. The Booroola mutation in sheep is associated with an alteration of the bone morphogenetic protein receptor-IB functionality. J Endocrinol. 2003;177:435-444
51. McNatty KP, Lun S, Heath DA, et al. Differences in ovarian activity between booroola X merino ewes which were homozygous, heterozygous and non-carriers of a major gene influencing their ovulation rate. J Reprod Fertil. 1986;77:193-205
52. Monget P, Fabre S, Mulsant P, et al. Regulation of ovarian folliculogenesis by IGF and BMP system in domestic animals. Domest Anim Endocrinol. 2002;23:139-154
53. Souza CJ, Campbell BK, McNeilly AS, Baird DT. Bone morphogenetic proteins and folliculogenesis: lessons from the Booroola mutation. Reprod Suppl. 2003;61:361-370
54. Le Bellego F, Pisselet C, Huet C, Monget P, Monniaux D. Laminin-α6ß1 integrin interaction enhances survival and proliferation and modulates steroidogenesis of ovine granulosa cells. J Endocrinol. 2002;172:45-59
55. Legeai L, Vigier B, Tran D, Picard JY, Josso N. Monoclonal antibodies raised against bovine anti-müllerian hormone: bovine, ovine, and caprine hormones share a set of identical epitopes. Biol Reprod. 1986;35:1217-1225
56. Monniaux D, Clemente Nd, Touzé JL, et al. Intrafollicular steroids and anti-mullerian hormone during normal and cystic ovarian follicular development in the cow. Biol Reprod. 2008;79:387-396
57. Lukas-Croisier C, Lasala C, Nicaud J, et al. Follicle-stimulating hormone increases testicular anti-Mullerian hormone (AMH) production through sertoli cell proliferation and a nonclassical cyclic adenosine 5-monophosphate-mediated activation of the AMH gene. Mol Endocrinol. 2003;17:550-561
58. Val P, Lefrancois-MartinezAM,Veyssiere G, Martinez.ASF-1 a key player in the development and differentiation of steroidogenic tissues. Nucl Recept. 2003;1:8
59. Ishida W, Hamamoto T, Kusanagi K, et al. Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. J Biol Chem. 2000;275:6075-6079
60. Lahoz B, Alabart JL, Monniaux D, Mermillod P, Folch J. Anti-Mullerian hormone plasma concentration in prepubertal ewe lambs as a predictor of their fertility at a young age. BMC Vet Res. 2012; 8:118
61. Rosemary Siafakas A, Richardson DR. Growth arrest and DNA damage-45 α (GADD45α). Int J Biochem Cell Biol. 2009;41:986-989
62. Salvador JM, Brown-Clay JD, Fornace AJ Jr. Gadd45 in stress signaling, cell cycle control, and apoptosis. Adv Exp Med Biol. 2013; 793:1-19
63. Ruoss C, Tadros A, O'Shea T, McFarlane J, Almahbobi G. Ovarian follicle development in Booroola sheep exhibiting impaired bone morphogenetic protein signalling pathway. Reproduction. 2009; 138:689-696
64. McNatty KP, Juengel JL, Wilson T, Galloway SM, Davis GH. Genetic mutations influencing ovulation rate in sheep. Reprod Fertil Dev. 2001;13:549-555
65. Fabre S, Pierre A, Mulsant P, et al. Regulation of ovulation rate in mammals: contribution of sheep genetic models. Reprod Biol Endocrinol. 2006;4:20
66. Scaramuzzi RJ, Baird DT, Campbell BK, et al. Regulation of folliculogenesis and the determination of ovulation rate in ruminants. Reprod Fertil Dev. 2011;23:444-467
67. ten Dijke P, Yamashita H, Ichijo H, et al. Characterization of type I receptors for transforming growth factor-ß and activin. Science. 1994;264:101-104
68. Aoki H, Fujii M, Imamura T, et al. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sci. 2001;114:1483-1489
69. Glister C, Satchell L, Knight PG. Changes in expression of bone morphogenetic proteins (BMPs), their receptors and inhibin co-receptor betaglycan during bovine antral follicle development: Inhibin can antagonize the suppressive effect of BMPs on thecal androgen production. Reproduction. 2010;140:699-712
70. Ebisawa T, Tada K, Kitajima I, et al. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J Cell Sci. 1999;112(Pt 20):3519-3527
71. Pulkki MM, Mottershead DG, Pasternack AH, et al. A covalently dimerized recombinant human bone morphogenetic protein-15 variant identifies bone morphogenetic protein receptor type 1B as a key cell surface receptor on ovarian granulosa cells. Endocrinology. 2012;153:1509-1518
72. De Santa Barbara P, Bonneaud N, Boizet B, et al. Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Müllerian hormone gene. Mol Cell Biol. 1998;18:6653-6665
73. Shen WH, Moore CC, Ikeda Y, Parker KL, Ingraham HA. Nuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: A link to the sex determination cascade. Cell. 1994; 77:651-661
74. Giuili G, Shen WH, Ingraham HA. The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian inhibiting substance, in vivo. Development. 1997;124:1799-1807
75. Watanabe K, Clarke TR, Lane AH, Wang X, Donahoe PK. Endogenous expression of Müllerian inhibiting substance in early postnatal rat sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites. Proc Natl Acad Sci USA. 2000;97:1624-1629
76. Tremblay JJ, Viger RS. Transcription factor GATA-4 enhances Müllerian inhibiting substance gene transcription through a direct interaction with the nuclear receptor SF-1. Mol Endocrinol. 1999; 13:1388-1401
77. Kido S, Kuriwaka-Kido R, Umino-Miyatani Y, et al. Mechanical stress activates Smad pathway through PKCß to enhance interleukin-11 gene transcription in osteoblasts.PLoSOne. 2010;5:e13090
78. Brown CO3rd, Chi X, Garcia-Gras E, Shirai M, Feng XH, Schwartz RJ. The cardiac determination factor, Nkx2-5, is activated by mutual cofactors GATA-4 and Smad1/4 via a novel upstream enhancer. J Biol Chem. 2004;279:10659-10669.